Challenges in Revising Multi-Owner SOPs
Unlike departmental SOPs managed by a single owner, multi-owner SOPs involve:
Click to read the full article.
The Ultimate Resource for Pharmaceutical SOPs and Best Practices
Unlike departmental SOPs managed by a single owner, multi-owner SOPs involve:
Click to read the full article.
Before implementing changes to an SOP, it is critical to understand:
Click to read the full article.
When an SOP is revised or replaced, multiple risks may surface:
Click to read the full article.
SOP revisions aren’t merely editorial changes—they often introduce new steps, eliminate old practices, or align procedures with current GMP guidelines. Every change must be evaluated not just for correctness but for its impact on operations, quality, training, and compliance.
Click to read the full article.
SOP version conflicts occur when multiple versions of the same procedure are simultaneously in circulation or use. This can result in:
Click to read the full article.
In one 483, FDA noted that multiple versions of an SOP on sampling procedures were found on the same shared drive. Operators accessed different versions, leading to non-uniform practices in microbiological sampling.
Click to read the full article.
Traditional SOP revision methods involve paper-based updates, emails, manual sign-offs, and scattered file storage. These introduce multiple challenges:
Click to read the full article.
The revision to ICH Q9 on Quality Risk Management emphasized better data-driven decisions and the use of risk-based approaches in routine operations. Companies were expected to revise their SOPs on:
Click to read the full article.
A robust framework should include:
Click to read the full article.
The review frequency should be based on document criticality, risk, and regulatory requirements. Common practices include:
Click to read the full article.